TuHURA Biosciences Inc.
Organization details
- Legal name
- TuHURA Biosciences Inc.
- Former names
- Kintara Therapeutics, Inc. DelMar Pharmaceuticals, Inc. Berry Only Inc.
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 2834 — Pharmaceutical Preparations
- Jurisdiction of incorporation
- Nevada
- Headquarters city
- Tampa
- Headquarters state / province
- Florida
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- HURA
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001498382
- EIN
- 99-0360497
Board of directors
-
Alan List · DirectorSince 2024
-
Craig Tendler · DirectorSince 2025
-
George K. Ng · DirectorSince 2024
-
James A. Bianco · Director · Chief Executive OfficerSince 2024
-
James S. J. Manuso · DirectorSince 2024
-
Laura L. Johnson · DirectorSince 2023
-
Robert E. Hoffman · Director · President, CEO and Interim CFOSince 2023
-
Robert Joseph Toth Jr. · DirectorSince 2023
-
Tamara A. Seymour · DirectorSince 2023
Chief executives
Director election results
Annual meeting of August 18, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
92.3%
-
98.6%
-
98.7%
-
98.7%
-
98.9%
-
98.9%
Board connections
5 of this board's directors also sit on 7 other boards. 7 are in the same sector.
-
Artelo Biosciences Inc. Same sectorvia Tamara A. Seymour
-
Calidi Biotherapeutics Inc. Same sectorvia George K. Ng
-
FibroBiologics Inc. Same sectorvia Robert E. Hoffman
-
Opus Genetics Inc. Same sectorvia James S. J. Manuso
-
Parabilis Medicines Inc. Same sectorvia Craig Tendler
-
Processa Pharmaceuticals Inc. Same sectorvia George K. Ng
-
Zevra Therapeutics Inc. Same sectorvia Tamara A. Seymour
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| May 28, 2026 | James A. Bianco Director, Officer (Chief Executive Officer) | Gift | −150,000 | — | — |
| Oct 18, 2024 | James A. Bianco Director, Officer (Chief Executive Officer) | Grant or award | +2,323,307 | — | — |
| Jun 1, 2023 | Robert E. Hoffman Director, Officer (President, CEO, and CFO) | Grant or award | +59,800 | — | — |
| Jan 5, 2023 | Brown Dennis M Officer (Chief Scientific Officer) | Inheritance | +363 | — | — |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about TuHURA Biosciences Inc.
Who is the CEO of TuHURA Biosciences Inc.?
James A. Bianco has been TuHURA Biosciences Inc.'s Chief Executive Officer since October 2024.
How many directors are on TuHURA Biosciences Inc.'s board?
TuHURA Biosciences Inc.'s board has 9 directors: Alan List, Craig Tendler, George K. Ng, James A. Bianco, James S. J. Manuso, Laura L. Johnson, Robert E. Hoffman, Robert Joseph Toth Jr. and Tamara A. Seymour.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="tuhura-biosciences-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.